Retrograde Autologous Priming For Cardiopulmonary Bypass: A Safe And Effective Means Of Decreasing Hemodilution And Transfusion Requirements
Todd K. Rosengart(Baylor College of Medicine), Karl H. Krieger(NewYork–Presbyterian Hospital), Samuel J. Lang(Cornell University), M E Vega Gómez(NewYork–Presbyterian Hospital), Wilson Ko(National Taiwan University), Robert E. Helm(NewYork–Presbyterian Hospital), Gregg S. Hartman(NewYork–Presbyterian Hospital), Maureen O’Hara(NewYork–Presbyterian Hospital), William DeBois(NewYork–Presbyterian Hospital), O. Wayne Isom(NewYork–Presbyterian Hospital), Nasser K. Altorki(Cornell University)
Cited by 145
Related Papers
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
|Nature|2015|1.8k
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
|The Lancet|2021|1.5k
Angiogenesis Gene Therapy
|Circulation|1999|661
Outcomes of 3309 thoracoabdominal aortic aneurysm repairs
|Journal of Thoracic and Cardiovascular Surgery|2016|652
Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer
|Annals of Surgical Oncology|2011|331